Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
09/2010
09/29/2010CN101094666B Improvement of image quality in the eye
09/28/2010US7803939 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
09/28/2010US7803811 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors
09/28/2010US7803399 Delivery system for nucleic acids
09/28/2010CA2493765C Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
09/28/2010CA2481707C Benzopyran derivatives substituted with secondary amines having tetrazole, method for the preparation thereof and pharmaceutical compositions containing them
09/28/2010CA2386417C Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity
09/28/2010CA2308201C Use of anti-fungal agents for the treatment of fungus-induced mucositis
09/23/2010WO2010107069A1 Amino acid-containing ophthalmic composition
09/23/2010WO2010106988A1 Amide derivative
09/23/2010WO2010106871A1 Osmotic pressure-controlling agent
09/23/2010WO2010106494A1 Use of pharmaceutical compositions containing mesembrenone
09/23/2010WO2010105450A1 A layered double hydroxide complex inserted by carnosine and the preparation method thereof
09/23/2010WO2010075315A3 Topical formulations of flap inhibitors for administration to an eye
09/23/2010WO2010073011A3 Heterocyclic compounds and their use as ampk activators
09/23/2010US20100240764 Use of S-Clenbuterol
09/23/2010US20100240743 Cannabinoid receptor modulator
09/23/2010US20100240742 Anti-angiogenic compositions and methods of use
09/23/2010US20100240734 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
09/23/2010US20100240718 Novel heteroaryl-substituted acetone derivative, suitable for inhibiting phospholipase a2
09/23/2010US20100240686 Chemical compounds
09/23/2010US20100240685 2-S-Benzyl Substituted Pyrimidines As CRTH2 Antagonists
09/23/2010US20100240679 4-Phenylpiperidine Derivatives as Renin Inhibitors
09/23/2010US20100240677 Compounds as PDE IV and TNF Inhibitors
09/23/2010US20100240663 Heterocycles as potassium channel modulators
09/23/2010US20100240650 Substituted pyrrolines as kinase inhibitors
09/23/2010US20100240625 Ophthalmic Formulations of Cetirizine and Methods of Use
09/23/2010US20100240624 Ophthalmic Formulations of Ketotifen and Methods of Use
09/23/2010US20100240623 8-oxoadenine derivatives acting as modulators of tlr7
09/23/2010US20100240622 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
09/23/2010US20100240614 Indole Compounds Bearing Aryl or Heteroaryl Groups Having Sphingosine 1-Phosphate (S1P) Receptor Biological Activity
09/23/2010US20100239580 Taci-immunoglobulin fusion proteins for treatment of optic neuritis
09/23/2010US20100239499 Methods and compositions for genetic and retinal disease
09/23/2010CA2755697A1 Amide derivative
09/22/2010EP2229361A1 Tetrahydroindoles having sphingosine-1-phosphate receptor activity
09/22/2010EP2229180A1 Composition comprising superoxide dismutase and carboxv methyl beta-1,3 glucan
09/22/2010CN1852708B Human beta-defensin secretion promoter
09/22/2010CN101838328A Anti-vegf antibodies
09/22/2010CN101837070A Preparation method for medlar radix rehmanniae wine
09/22/2010CN101837066A Application of golden thread detoxication decoction as compound preparation in preparing IOD active medicaments
09/22/2010CN101837061A New applications of Hawthorn leaves and extract thereof
09/22/2010CN101837012A Method for preparing iron wine
09/22/2010CN101836954A Method for preparing stable xanthophyll-oil suspension
09/21/2010US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
09/21/2010US7799795 chemokine receptor modulators such as N-(1-(3-(4-cyanophenyl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)ethyl)-N-(2-(ethylsulfonyl)ethyl)-2-(4-fluoro-3-(trifluoromethyl)phenyl)-acetamide, used for the treatment of asthma, allergic and autoimmune diseases
09/21/2010US7799786 Therapeutic agents useful for treating pain
09/21/2010US7799775 Pyrimidine derivatives
09/21/2010US7799763 Muscle-strengthening drugs and anti-inflammatory drugs
09/21/2010CA2477720C Quinoline derivatives
09/21/2010CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2434178C Substituted amine derivatives and methods of use
09/21/2010CA2417148C Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/21/2010CA2396045C Aqueous ionic solutions and their uses in particular in ophthalmology
09/21/2010CA2386549C Polymorphic b form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5h-furan-2-one
09/16/2010WO2010105079A1 Complex of polymeric quaternary ammonium and anionic polymers as a new antimicrobial agent for ophthalmic compositions
09/16/2010WO2010104187A1 Steroid compound
09/16/2010WO2010104093A1 Prophylactic or therapeutic agent for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivative or salt thereof as active ingredient
09/16/2010WO2010104024A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010WO2010103683A1 Topical therapeutic agent for ophthalmic diseases comprising compound capable of binding specifically to dna sequence
09/16/2010WO2010103120A1 New crystals of a benzoylbenzeneacetamide derivative
09/16/2010WO2010102512A1 C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof
09/16/2010US20100234336 Ophthalmic Compositions
09/16/2010US20100234334 Nitric oxide releasing steroids
09/16/2010US20100234333 Novel quinuclidine derivatives and medicinal compositions containing the same
09/16/2010US20100234318 Ophthalmic composition containing alginic acid or salt thereof
09/16/2010US20100234293 Novel Neurotrophic Factors
09/16/2010US20100233287 Preventing or treating agent for glaucoma
09/16/2010US20100233283 Medicinal compositions containing honey
09/16/2010US20100233255 Combination of trazine derivatives and insulin secretion stimulators
09/16/2010US20100233241 Ophthalmic drug delivery system and applications
09/16/2010US20100233240 Corneal endothelial preparation which enables cells to grow in vivo
09/16/2010US20100233194 Treatment of neovascular ocular disease states
09/16/2010US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides
09/16/2010US20100233153 Novel gene disruptions, compositions and the methods relating thereto
09/16/2010US20100233145 Composition used as a nutritional supplement and medication for the treatment of degenerative visual disorders and inflammation
09/16/2010CA2755314A1 New crystals of a benzoylbenzeneacetamide derivative
09/16/2010CA2755118A1 Preventive or therapeutic agents for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivatives or salts thereof as active ingredients
09/16/2010CA2755106A1 Complex of polymeric quaternary ammonium and anionic polymers as a new antimicrobial agent for ophthalmic compositions
09/16/2010CA2754613A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010CA2754589A1 Steroid compound
09/15/2010EP2228389A2 Antibodies against vascular endothelial growth factor 2
09/15/2010EP2228385A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
09/15/2010EP2228384A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
09/15/2010EP2228058A1 Anionic oil-in-water emulsion containing prostaglandins and uses thereof
09/15/2010EP2228057A1 Cationic oil-in-water emulsions containing prostaglandins and uses thereof
09/15/2010EP1611144B1 Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists
09/15/2010CN101835491A Agent for promoting corneal endothelial cell adhesion
09/15/2010CN101835469A 1-amino-alkylcyclohexane derivatives for the treatment and prevention of hearing loss
09/15/2010CN101830889A 嘧啶衍生物 Pyrimidine derivatives
09/15/2010CN101830792A Vitamin K3 derivatives serving as IDO inhibitor
09/15/2010CN101829304A Kedibao
09/15/2010CN101829251A Traditional Chinese medicine patch for treating deafness
09/15/2010CN101829199A Application of ranunculus japonicus extract in preparing anti-tumor and anti-tumor angiogenesis drugs
09/15/2010CN101829174A Application of erigeron breviscapus extract in preparing anti-tumor or angiogenesis-suppressing medicaments, health-care food or cosmetics
09/15/2010CN101829120A Composition for treatment of external secretion disorders
09/15/2010CN101829048A Eye drop and preparation method thereof
09/15/2010CN101264053B Oxybuprocaine hydrochloride eye drops and preparation thereof
09/15/2010CN101180068B Use of polysaccharides extracted from dendrobium in preparing medicine for treating autoimmune disease uveitis
1 ... 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 ... 531